Yongzhan Nie
- Cancer Research top 0.1%
- MicroRNA in disease regulation 39
- Cancer-related molecular mechanisms research 31
- Molecular Biology top 0.5%
- RNA modifications and cancer 38
- Glycosylation and Glycoproteins Research 36
- Epigenetics and DNA Methylation 21
- Gastroenterology top 0.5%
- Gastrointestinal motility and disorders 19
- Oncology top 1%
- Peptidase Inhibition and Analysis 18
- Geriatrics and Gerontology top 1%
-
- Monoclonal and Polyclonal Antibodies Research 17
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Yongzhan Nie
296 papers receiving 14.0k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Cancer Research 4.6k
- Molecular Biology 9.2k
- Gastroenterology 549
- Oncology 2.3k
- Geriatrics and Gerontology 278
Countries citing papers authored by Yongzhan Nie
This map shows the geographic impact of Yongzhan Nie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongzhan Nie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongzhan Nie more than expected).
Fields of papers citing papers by Yongzhan Nie
This network shows the impact of papers produced by Yongzhan Nie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongzhan Nie. The network helps show where Yongzhan Nie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yongzhan Nie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 12 | |
| 7 | 2022 | 61 | |
| 8 | 2021 | 27 | |
| 9 | 2020 | 16 | |
| 10 | EMP1 Promotes the Proliferation and Invasion of Ovarian Cancer Cells Through Activating the MAPK Pathway | 2020 | 1 |
| 11 | 2020 | 13 | |
| 12 | 2020 | 23 | |
| 13 | 2019 | 74 | |
| 14 | 2019 | 31 | |
| 15 | 2018 | 53 | |
| 16 | 2017 | 122 | |
| 17 | 2017 | 1 | |
| 18 | 2016 | 41 | |
| 19 | 2016 | 60 | |
| 20 | 2014 | 87 |
About Yongzhan Nie
Yongzhan Nie is a scholar working on Cancer Research, Gastroenterology and Oncology, having authored 306 papers that have together received 14.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (39 papers), RNA modifications and cancer (38 papers), Glycosylation and Glycoproteins Research (36 papers), Cancer-related molecular mechanisms research (31 papers), Epigenetics and DNA Methylation (21 papers), Gastrointestinal motility and disorders (19 papers), Peptidase Inhibition and Analysis (18 papers) and Monoclonal and Polyclonal Antibodies Research (17 papers). The work is most often cited by research in Cancer Research (4.6k citations), Molecular Biology (9.2k citations) and Gastroenterology (549 citations). Yongzhan Nie has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Daiming Fan, Kaichun Wu, Yongquan Shi, Zhiping Yang, Qiong Wu, Yuanyuan Lu, Xiaodi Zhao, Limin Xia, Qingchuan Zhao and Yulong Shang. Their work appears in journals such as Theranostics, Cancer Letters, Oncogene, Oncotarget and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.